C44.81
C44.81 — Basal cell carcinoma of overlapping sites of skin
Billable / specific codeICD-10-CM
C44.81 is a billable, specific ICD-10-CM code for basal cell carcinoma of overlapping sites of skin. It is valid for submission on a claim.
Risk adjustment
C44.81 does not map to an HCC and does not risk-adjust under CMS-HCC V28. That is normal — most ICD-10 codes do not. It still needs to be coded correctly; it just will not move a RAF score.
Medicare coverage
C44.81 is named in 58 Medicare coverage policies — 58 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.
- A52450Billing and Coding: Paclitaxel (e.g., Taxol®/Abraxane ™)
- A52479Oral Anticancer Drugs - Policy Article
- A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
- A53883Billing and Coding: Mohs Micrographic Surgery (MMS)
Related codes at this level
Codes that share C44.8. If C44.81 is not quite right, the correct code is usually one of these.
Questions about C44.81
- Is C44.81 a billable ICD-10-CM code?
- Yes. C44.81 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
- Where does C44.81 sit in the tabular list?
- Neoplasms (C00-D49), in the block Melanoma and other malignant neoplasms of skin (C43-C44).